3137 results for «785»
3137 results
Rapid-fire - Mitral TEER for complex situations
18 Feb 2024 – From PCR Tokyo Valves 2024
This series of rapid-fire submitted cases focuses on mitral TEER for complex situations. Learn about creative solutions to these situations such as clip inversion grasping, independent leaflet grasping with a CGA system, and more!
Rapid-fire - Vascular access in TAVI
17 Feb 2024 – From PCR Tokyo Valves 2024
Discover a selection of rapid-fire TAVI vascular access cases: how to deliver a transcatheter heart valve in a calcified aorta, using the buddy wire technique in TAVR with severely tortuous aorta, and more!
Tailoring the TEER for an Asian patient
17 Feb 2024 – From PCR Tokyo Valves 2024
In this special session sponsored by Abbott, stay up to date with the latest real-world data from the EXPAND G4 study, understand the challenges that Asian heart anatomy presents for TEER therapy, and learn how the four clip sizes of the G4 MitraClip system can be...
Unraveling aortic valve complexities: grading challenges, intervention decisions, and advanced imaging techniques
02 Feb 2024 – From PCR Imaging Valves Madrid 2024
Explore the complexities of aortic valve disorders in this PCR Imaging Valves Madrid 2024 session, covering topics from grading challenges to intervention decisions in both asymptomatic and symptomatic patients, and learn more about advanced imaging techniques for quantifying aortic regurgitation severity and navigating treatment choices for...
The aortic regurgitation problem: an imaging and practical perspective
02 Feb 2024 – From PCR Imaging Valves Madrid 2024
In this session, discover strategies to address biases in aortic regurgitation, influenced by factors like etiology, natural history, surgical risk, age, and gender, and explore an imaging-centric approach to better quantify aortic regurgitation and comprehend its relationship with left ventricular remodeling and outcomes. Anticipate forthcoming guidelines...
Optimizing case selection and procedure guidance in transcatheter mitral valve interventions
02 Feb 2024 – From PCR Imaging Valves Madrid 2024
This session examines the critical aspect of case selection for various transcatheter mitral valve interventions, ranging from TEER in secondary mitral regurgitation to balloon valvotomy in mitral stenosis and transcatheter mitral valve replacement. It explores the intricacies of procedure planning and guidance for TEER, alongside methods...
Advanced imaging strategies in transcatheter tricuspid valve therapies
03 Feb 2024 – From PCR Imaging Valves Madrid 2024
In this PCR Imaging Valves Madrid 2024 session, discover the use of various imaging techniques in transcatheter tricuspid valve therapies, ranging from standard TEE screening to comprehensive intra-procedural assessments, facilitating optimal device selection, procedural success, and post-procedural monitoring.
TAVI for patients with concomitant coronary artery disease - LIVE case
17 Feb 2024 – From PCR Tokyo Valves 2024
An 88-year-old male presented a severe symptomatic aortic valve with preserved LV function (64%), a coronary artery disease with a LAD PCI a few years ago and a significant (75%) RCA stenosis with an FFR angio at 0.74. He also has a short membrane septum (2.5...
PCR Tokyo Valves 2024 Welcome Ceremony
17 Feb 2024 – From PCR Tokyo Valves 2024
After a brief overview of the Course's history and the success of the PCR Family's various Courses, join the Course Directors as they unveil the new venue for the 2024 edition, introduce the team, and reveal the schedule for three intense days featuring a diverse and...
Challenges in TEER for secondary mitral regurgitation
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore this session on secondary mitral regurgitation to understand the ideal case predictors gleaned from trials like EVEREST, COAPT, or MITRA-FR, delve into patient selection conundrums, including optimal medical therapy, examine technical challenges posed by atrial functional mitral regurgitation, and gain insights into TEER techniques for...
The optimal first valve choice for patients with aortic stenosis - Key considerations for lifetime management
17 Feb 2024 – From PCR Tokyo Valves 2024
This session tackles the pressing topic of TAVI's success in treating aortic stenosis, particularly in younger patients, and the ensuing questions regarding device durability, potential follow-up procedures, and the interplay between TAVI and surgical options. The aim is to ensure optimal decision-making that prioritizes patient welfare...
Achieving the optimal outcome using the latest self-expandable TAVI - LIVE case
17 Feb 2024 – From PCR Tokyo Valves 2024
An 86-year-old woman presented severe symptomatic aortic stenosis and coronary artery disease with a preserved LV function. The operators performed a PCI of the RCA ostium one month ago. The CT showed a small femoral access (diameter: 5.3 to 4.9 mm).
After a predilatation with a 20 mm...
Rapid-fire - Mitral TEER for special situations
17 Feb 2024 – From PCR Tokyo Valves 2024
Gain valuable insights into the possible complications of Mitral Transcatheter Edge-to-Edge Repair (TEER) in the first part of this session rapid-fire submission cases [in Japanese].
Contemporary techniques for TAV-in-SAV interventions
18 Feb 2024 – From PCR Tokyo Valves 2024
Thanks to this session, take a look at the current outcomes of TAV-in-SAV, analyse the different types of valves and their fracturability, find out more, through case studies, about two different TAV-in-SAV techniques, with or without a stent, and learn how to avoid patient prosthesis mismatch...
Primary mitral regurgitation edge to edge repair with one device - LIVE case
18 Feb 2024 – From PCR Tokyo Valves 2024
An 83-year-old male presented symptomatic severe PMR due to lateral P2 chordal rupture, small LA and preserved LV function (68%). Watch the operators implant one XTW clip successfully.
LIVE case from Sendai Kousei Hospital - Sendai, Japan
Navigate the video by moving your mouse over the chapter icon in...
Shaping the future of structural heart disease intervention
18 Feb 2024 – From PCR Tokyo Valves 2024
Consult this session if you want to discuss the remaining challenges of transcatheter valvular interventions, and to review latest innovations for structural heart disease.
Late-Breaking Trial session
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore pivotal findings from registries and studies, including the OCEAN-TAVI Registry on PPM prevalence in Asian TAVR patients, SIL-TAVI Registry insights on TAVI outcomes in cancer patients, the EXPAND G4 study's outcomes for Japanese MitraClip G4 recipients, and TRISTAR study's 30-day results on K-Clip for tricuspid...
Heart Team in action: managing complex cases together
17 Feb 2024 – From PCR Tokyo Valves 2024
In this group discussion, several heart teams present their work on complex cases of tricuspid valve interventions and explore the results of their collaboration in order to figure out adequate management for invasive treatments.
TAVI and future coronary access - LIVE case
18 Feb 2024 – From PCR Tokyo Valves 2024
An 81-year-old woman, with a history of breast cancer surgery, stroke, and lymphoma remission, presented a severe symptomatic aortic stenosis associated with a suspicion of right coronary artery disease on the CT. The operators decided to perform TAVI first and then control the RCA by angiography...
The role of WATCHMAN therapy in optimising results and future perspectives
17 Feb 2024 – From PCR Tokyo Valves 2024
This special session sponsored by Boston Scientific will help you understand the latest status and the value of WATCHMAN therapy, as well as learning about future perspectives of LAA closure by new WATCHMAN FLX pro.